A new regimen of cisplatin, epirubicin and methotrexate (PEM-3) as primary chemotherapy for locally advanced bladder cancer.
Cacciari N, Martoni A, Rossi AP, Turci P, Lelli G, Martinelli A, Maver P, Corrado F, Mannini D, Reggiani A, Concetti S, Martelli A, Melotti B, Cricca A, Zamagni C, Pannuti F.
Cacciari N, et al. Among authors: melotti b.
Tumori. 1996 Jul-Aug;82(4):364-8. doi: 10.1177/030089169608200413.
Tumori. 1996.
PMID: 8890971
Clinical Trial.